HL
Haleon plc
HLNCF · OTC
$4.46 +1.36% (+$0.06)
1M -10.75%
Market Cap £29.4B
P/E Ratio 19.29x
Div. Yield 3.00%
ROE 9.40%
Bulios Fair Price
$2.24
49.8% downside
Trenutna cena
$4.46
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HLNCF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Strong
7/9Valuation
73 /100
Cheap P/E 19.29x
PEG 1.13x
EV/EBITDA 14.12x
Growth
50 /100
Stable EPS growth 19.98%
Book val. growth 0.19%
Rev. growth 0.52%
Profitability
92 /100
Strong Gross margin 61.81%
FCF margin 20.98%
Net margin 13.81%
Quality
37 /100
Average ROIC 6.10%
Asset turnover 0.34x
ROE 9.40%
Debt
59 /100
Moderate Debt/Equity 0.52x
Net debt/EBITDA 2.80x
Current ratio 0.92x
Stability
72 /100
Stable Beta 0.24x
Profitable years 6
Rev. volatility 3.12%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HLNCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Brian James McNamara
Employees
24,561
Headquarters
Weybridge
Prihajajoči dogodki
04 MAR.
Earnings
Upcoming earnings report